Insmed Incorporated

INSM

$162.58

Name : Insmed Incorporated

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $34,364,256,256.00

EPSttm : -5.66

Insmed Incorporated

$162.58

0.16%

$0.255

Float Short %

5.1

Margin Of Safety %

Put/Call OI Ratio

1.03

EPS Next Q Diff

0.56

EPS Last/This Y

0.03

EPS This/Next Y

1.93

Price

162.38

Target Price

167.59

Analyst Recom

1.15

Performance Q

68.26

Relative Volume

0.63

Beta

1.03

Ticker: INSM

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	INSM	146.7	0.95	0.47	102932
2025-09-09	INSM	147.27	0.95	0.22	103897
2025-09-10	INSM	145.94	0.94	0.66	104919
2025-09-11	INSM	145.78	0.95	0.24	105755
2025-09-12	INSM	145.9	0.96	0.36	105643
2025-09-15	INSM	142.68	0.97	0.22	105699
2025-09-16	INSM	144.8	0.97	0.45	106437
2025-09-17	INSM	144.78	0.97147517283562	0.38302752293578	106367
2025-09-18	INSM	145.63	0.97	0.36	106458
2025-09-19	INSM	144.76	0.95	0.25	111984
2025-09-22	INSM	144.97	0.85	0.77	86538
2025-09-23	INSM	145.32	0.85	0.60	87488
2025-09-24	INSM	140.99	0.86	0.66	87517
2025-09-25	INSM	135.54	0.86	3.38	87687
2025-09-26	INSM	137.05	0.94	7.13	93696
2025-09-29	INSM	141.66	0.94	8.82	93845
2025-09-30	INSM	143.94	0.96	0.57	95299
2025-10-01	INSM	147.28	0.96	1.66	95397
2025-10-02	INSM	152.81	0.97	0.69	95639
2025-10-03	INSM	157.16	0.97	0.84	96662
2025-10-06	INSM	158.29	1.01	0.34	98826
2025-10-07	INSM	162.36	1.03	1.19	100051
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	INSM	146.68	-7.2	425.8	-5.55
2025-09-09	INSM	147.25	-7.2	429.6	-5.55
2025-09-10	INSM	145.91	-7.2	436.4	-5.55
2025-09-11	INSM	145.79	-7.2	432.2	-5.55
2025-09-12	INSM	145.94	-7.2	431.1	-5.55
2025-09-15	INSM	143.12	-7.2	442.1	-5.55
2025-09-16	INSM	144.75	-7.2	425.6	-5.55
2025-09-17	INSM	144.75	-7.2	432.0	-5.55
2025-09-18	INSM	145.87	-7.2	427.6	-5.55
2025-09-19	INSM	144.77	-7.2	435.7	-5.55
2025-09-22	INSM	145.03	-7.2	430.6	-5.55
2025-09-23	INSM	145.37	-7.2	430.4	-5.55
2025-09-24	INSM	140.98	-7.2	448.1	-5.55
2025-09-25	INSM	135.59	-7.2	452.5	-5.55
2025-09-26	INSM	137.03	-7.2	425.9	-5.55
2025-09-29	INSM	141.67	-7.2	413.3	-5.55
2025-09-30	INSM	143.97	-7.2	422.8	-5.55
2025-10-01	INSM	147.25	-7.2	419.5	-5.55
2025-10-02	INSM	152.63	-7.2	412.0	-5.55
2025-10-03	INSM	157.20	-7.2	416.1	-5.55
2025-10-06	INSM	158.31	-5.4	412.2	-5.55
2025-10-07	INSM	162.38	-5.4	417.7	-5.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	INSM	-18.55	5.96	5.08
2025-09-09	INSM	-18.55	5.96	5.08
2025-09-10	INSM	-18.55	5.96	5.08
2025-09-11	INSM	-18.62	5.96	5.11
2025-09-12	INSM	-18.62	5.96	5.10
2025-09-15	INSM	-21.64	5.95	5.10
2025-09-16	INSM	-21.64	5.95	5.10
2025-09-17	INSM	-21.64	5.95	5.10
2025-09-18	INSM	-21.64	5.95	5.10
2025-09-19	INSM	-21.64	5.95	5.10
2025-09-22	INSM	-21.52	5.97	5.10
2025-09-23	INSM	-21.52	5.97	5.10
2025-09-24	INSM	-21.52	5.97	5.10
2025-09-25	INSM	-21.52	5.97	5.10
2025-09-26	INSM	-21.52	5.97	5.10
2025-09-29	INSM	-21.52	5.99	5.10
2025-09-30	INSM	-21.52	5.99	5.10
2025-10-01	INSM	-21.52	5.99	5.10
2025-10-02	INSM	-21.52	5.99	5.10
2025-10-03	INSM	-21.52	5.99	5.10
2025-10-06	INSM	-21.42	3.37	5.10
2025-10-07	INSM	-21.42	3.37	5.10
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-1.7

Avg. EPS Est. Current Quarter

-1.36

Avg. EPS Est. Next Quarter

-1.14

Insider Transactions

-21.42

Institutional Transactions

3.37

Beta

1.03

Average Sales Estimate Current Quarter

114

Average Sales Estimate Next Quarter

156

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-1.1

Max Drawdown 5-Year %

-63.3

Target Price

167.59

P/E

Forward P/E

PEG

P/S

86.18

P/B

27.42

P/Free Cash Flow

EPS

-5.7

Average EPS Est. Cur. Y

-5.54

EPS Next Y. (Est.)

-3.6

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-259.82

Relative Volume

0.63

Return on Equity vs Sector %

-108

Return on Equity vs Industry %

-94.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

417.7

Insmed Incorporated

Sector: Healthcare

Industry: Biotechnology

Employees: 1271

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops gene therapy, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as is in pre-clinical development for gene therapy, next generation DPP1 inhibitor, deimmunized therapeutic protein, and synthetic rescue. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

stock quote shares INSM – Insmed Incorporated Stock Price stock today

news today INSM – Insmed Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch INSM – Insmed Incorporated yahoo finance google finance

stock history INSM – Insmed Incorporated invest stock market

stock prices INSM premarket after hours

ticker INSM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: INSM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y